• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Racial differences in bone loss and relation to menopause among HIV-infected and uninfected women.感染与未感染HIV的女性在骨质流失方面的种族差异及其与绝经的关系。
Bone. 2015 Aug;77:24-30. doi: 10.1016/j.bone.2015.04.018. Epub 2015 Apr 18.
2
The Impact of Human Immunodeficiency Virus and Menopause on Bone Mineral Density: A Longitudinal Study of Urban-Dwelling South African Women.人类免疫缺陷病毒和绝经对骨密度的影响:一项对城市居住的南非女性的纵向研究。
J Bone Miner Res. 2023 May;38(5):619-630. doi: 10.1002/jbmr.4765. Epub 2023 Feb 1.
3
Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study.HIV 感染和未感染女性的区域性身体成分与骨密度的关系:女性机构间 HIV 研究。
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):469-76. doi: 10.1097/QAI.0b013e31826cba6c.
4
Associations of Age at Menopause With Postmenopausal Bone Mineral Density and Fracture Risk in Women.绝经年龄与女性绝经后骨密度和骨折风险的关系。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e561-e569. doi: 10.1210/clinem/dgab690.
5
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.中年 HIV 感染和未感染女性的骨密度前瞻性评估:美沙酮使用与骨丢失的关系。
Maturitas. 2011 Nov;70(3):295-301. doi: 10.1016/j.maturitas.2011.08.003. Epub 2011 Sep 25.
6
Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women.丙型肝炎和 HIV 合并感染的绝经后少数族裔妇女的骨密度和微结构。
Osteoporos Int. 2018 Apr;29(4):871-879. doi: 10.1007/s00198-017-4354-z. Epub 2018 Feb 1.
7
A prospective study of bone loss in menopausal Australian-born women.对澳大利亚出生的绝经后女性骨质流失的前瞻性研究。
Osteoporos Int. 1998;8(3):282-90. doi: 10.1007/s001980050066.
8
CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.CD4 细胞计数与 50 岁以下 HIV 感染男性的腰椎骨量呈负相关。
Osteoporos Int. 2019 Jul;30(7):1501-1510. doi: 10.1007/s00198-019-04942-7. Epub 2019 Mar 26.
9
Longitudinal analysis of bone density in human immunodeficiency virus-infected women.人类免疫缺陷病毒感染女性骨密度的纵向分析。
J Clin Endocrinol Metab. 2006 Aug;91(8):2938-45. doi: 10.1210/jc.2006-0127. Epub 2006 May 30.
10
Factors affecting bone loss around menopause in women without HRT: a prospective study.无激素替代疗法的绝经后女性骨量流失的影响因素:一项前瞻性研究。
Maturitas. 2003 Jul 25;45(3):159-67. doi: 10.1016/s0378-5122(03)00150-6.

引用本文的文献

1
Breaking Down Bone Disease in People Living with HIV: Pathophysiology, Diagnosis, and Treatment.解析HIV感染者的骨病:病理生理学、诊断与治疗
Adv Exp Med Biol. 2025;1476:87-110. doi: 10.1007/5584_2024_831.
2
Bone mass, fracture risk, and associated factors in postmenopausal women living with HIV.绝经后 HIV 感染者的骨量、骨折风险及相关因素。
Menopause. 2024 Jan 1;31(1):46-51. doi: 10.1097/GME.0000000000002293. Epub 2023 Dec 18.
3
Obesity among women with HIV.感染艾滋病毒的女性中的肥胖问题。
Curr Opin HIV AIDS. 2024 Jan 1;19(1):30-34. doi: 10.1097/COH.0000000000000828. Epub 2023 Nov 1.
4
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS).HIV 阳性女性绝经过渡:来自瑞士 HIV 队列研究(SHCS)的见解。
HIV Med. 2022 Apr;23(4):417-425. doi: 10.1111/hiv.13255. Epub 2022 Feb 22.
5
Evaluation of Adherence to Guideline-Based Bone Mineral Density Screening in Veterans with HIV.评估 HIV 退伍军人基于指南的骨密度筛查的依从性。
AIDS Res Hum Retroviruses. 2022 Mar;38(3):216-221. doi: 10.1089/AID.2021.0095. Epub 2022 Jan 24.
6
Obesity, Vascular Disease and Frailty in Aging Women with HIV.感染HIV的老年女性中的肥胖、血管疾病和虚弱
Adv Geriatr Med Res. 2021;3(3). doi: 10.20900/agmr20210014. Epub 2021 Jun 22.
7
Sex-specific and age-specific characteristics of body composition and its effect on bone mineral density in adults in southern China: a cross-sectional study.中国南方成年人身体成分的性别和年龄特异性特征及其对骨密度的影响:一项横断面研究
BMJ Open. 2020 Apr 19;10(4):e032268. doi: 10.1136/bmjopen-2019-032268.
8
Perspectives on menopause and women with HIV.关于更年期与感染艾滋病毒女性的观点。
Int J Womens Health. 2016 Jan 11;8:1-22. doi: 10.2147/IJWH.S62615. eCollection 2016.
9
Bone loss in HIV: a contemporary review.HIV感染中的骨质流失:当代综述
Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):446-51. doi: 10.1097/MED.0000000000000200.

本文引用的文献

1
Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study).在骨密度低的 HIV-1 感染患者中,从替诺福韦转换为阿巴卡韦后骨密度的改善:两项中心随机试点研究(OsteoTDF 研究)。
J Antimicrob Chemother. 2014 Dec;69(12):3368-71. doi: 10.1093/jac/dku300. Epub 2014 Aug 13.
2
Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks.从替诺福韦转换为拉替拉韦在48周内会增加低骨矿物质密度并降低骨转换标志物。
HIV Med. 2014 Jul;15(6):373-80. doi: 10.1111/hiv.12123. Epub 2014 Jan 26.
3
Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine.接受替诺福韦-恩曲他滨或阿巴卡韦-拉米夫定治疗的 HIV 感染者的骨转换和骨丢失变化。
PLoS One. 2012;7(6):e38377. doi: 10.1371/journal.pone.0038377. Epub 2012 Jun 15.
4
Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial.随机试验中,比较转换用阿巴卡韦或替诺福韦酯治疗对 HIV 感染成年人的骨和肾脏的影响。
PLoS One. 2012;7(3):e32445. doi: 10.1371/journal.pone.0032445. Epub 2012 Mar 29.
5
Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.绝经后 HIV 感染女性的骨丢失率更高:一项纵向研究。
J Clin Endocrinol Metab. 2012 Feb;97(2):554-62. doi: 10.1210/jc.2011-2197. Epub 2011 Nov 16.
6
Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN).多民族队列中与末次月经相关的骨密度丢失:来自妇女健康研究 across the Nation(SWAN)的结果。
J Bone Miner Res. 2012 Jan;27(1):111-8. doi: 10.1002/jbmr.534.
7
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.中年 HIV 感染和未感染女性的骨密度前瞻性评估:美沙酮使用与骨丢失的关系。
Maturitas. 2011 Nov;70(3):295-301. doi: 10.1016/j.maturitas.2011.08.003. Epub 2011 Sep 25.
8
Stable bone density in HAART-treated individuals with HIV: a meta-analysis.抗逆转录病毒治疗(HAART)治疗的 HIV 感染者中稳定的骨密度:一项荟萃分析。
J Clin Endocrinol Metab. 2011 Sep;96(9):2721-31. doi: 10.1210/jc.2011-0591. Epub 2011 Jun 29.
9
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.在接受依非韦伦或阿扎那韦-利托那韦联合治疗的抗逆转录病毒初治患者中,随机分配接受阿巴卡韦-拉米夫定或替诺福韦酯-富马酸二吡呋酯-恩曲他滨:艾滋病临床治疗试验组 A5224s,A5202 的子研究。
J Infect Dis. 2011 Jun 15;203(12):1791-801. doi: 10.1093/infdis/jir188.
10
Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.在 2000 年至 2006 年间,与美国普通人群相比,HIV 门诊研究(HOPS)中感染 HIV 的人群骨折发生率增加。
Clin Infect Dis. 2011 Apr 15;52(8):1061-8. doi: 10.1093/cid/ciq242. Epub 2011 Mar 10.

感染与未感染HIV的女性在骨质流失方面的种族差异及其与绝经的关系。

Racial differences in bone loss and relation to menopause among HIV-infected and uninfected women.

作者信息

Sharma Anjali, Flom Peter L, Rosen Clifford J, Schoenbaum Ellie E

机构信息

Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.

Peter Flom Consulting, New York, NY, USA.

出版信息

Bone. 2015 Aug;77:24-30. doi: 10.1016/j.bone.2015.04.018. Epub 2015 Apr 18.

DOI:10.1016/j.bone.2015.04.018
PMID:25896953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4418198/
Abstract

OBJECTIVE

To characterize changes in bone mineral density (BMD) according to race among HIV-infected and uninfected women, and to evaluate the relationship between race and menopause-related bone loss.

METHODS

Dual X-ray absorptiometry measured BMD on study entry and a minimum of 18 months later in 246 HIV-infected and 219 HIV-uninfected women in the Menopause Study. Linear regression analyses determined percent annual BMD change at the total hip (TH), femoral neck (FN), and lumbar spine (LS) after adjusting for potential confounders. Race-stratified and HIV-infected subgroup analyses were performed.

RESULTS

At baseline, mean age was 45 years, 19% of women were postmenopausal. HIV-infected women were more likely to be black (58% vs. 38%), and had lower BMI and less cigarette exposure when compared to HIV-uninfected women. Women who were perimenopausal at baseline and postmenopausal at follow-up had the greatest TH bone loss (-1.68%/yr, p < .0001) followed by those postmenopausal throughout (-1.02%/yr, p = .007). We found a significant interaction between HIV status and race in multivariate analyses of BMD change at the FN and TH. In race-stratified analyses, HIV infection was associated with TH BMD loss in non-black women. Black women experienced greater menopause-associated decline in TH BMD compared with non-black women.

CONCLUSIONS

The association of HIV and BMD differs strikingly by race, as do the effects of the menopausal transition on bone. Determining the extent to which the effect of HIV on fracture risk varies by race will be crucial to identify HIV-infected women at greatest risk for osteoporotic fracture, particularly as they enter menopause.

摘要

目的

描述感染和未感染HIV的女性中骨密度(BMD)随种族的变化情况,并评估种族与绝经相关骨质流失之间的关系。

方法

在绝经研究中,对246名感染HIV的女性和219名未感染HIV的女性在研究开始时及至少18个月后进行双能X线吸收法测量骨密度。线性回归分析在调整潜在混杂因素后确定全髋(TH)部、股骨颈(FN)和腰椎(LS)处的年骨密度变化百分比。进行了种族分层分析和感染HIV的亚组分析。

结果

基线时,平均年龄为45岁,19%的女性已绝经。与未感染HIV的女性相比,感染HIV的女性更可能是黑人(58%对38%),且BMI较低,吸烟较少。基线时处于围绝经期且随访时已绝经的女性全髋部骨质流失最多(-1.68%/年,p <.0001),其次是全程处于绝经后状态的女性(-1.02%/年,p =.007)。在对股骨颈和全髋部骨密度变化的多变量分析中,我们发现HIV感染状态与种族之间存在显著交互作用。在种族分层分析中,HIV感染与非黑人女性的全髋部骨密度流失有关。与非黑人女性相比,黑人女性全髋部骨密度的绝经相关下降幅度更大。

结论

HIV与骨密度的关联因种族而异,绝经过渡对骨骼的影响也是如此。确定HIV对骨折风险的影响在不同种族中差异的程度,对于识别骨质疏松性骨折风险最高的感染HIV女性至关重要,尤其是在她们进入绝经期时。